ISA Pharmaceuticals B.V. receives EUR 20m loan from European Investment Bank

ISA Pharmaceuticals Strengthens its Supervisory Board with the Addition of Dr. Markwin Velders

A One-Two Punch for HPV-16–positive Cancers?

Video interview with ISA CSO Prof. Dr. Cornelis Melief at AACR 2019

CRI Speaks with 2019 AACR-CRI Lloyd J. Old Award Recipient, Dr. Cornelis ‘Kees’ Melief

ISA Pharmaceuticals to Present Phase 2 Cervical Cancer Data at AACR Annual Meeting 2019

ISA Pharmaceuticals’ Chief Scientific Officer Prof. Dr. Cornelis Melief Receives AACR-CRI Lloyd J. Old Award in Cancer Immunology 2019

ISA Pharmaceuticals Announces Start of Phase 2 Combination Trial of ISA101b and Regeneron’s Cemiplimab in Oropharyngeal Cancer

ISA’s AMPLIVANT® publication selected as noteworthy article in the January edition of JITC Digest

ISA Pharmaceuticals´ Chief Scientific Officer Prof. Cornelis Melief to Present at Keystone Cancer Vaccines Conference